MedicinePOM

Aflibercept

An eye injection (VEGF inhibitor) for wet macular degeneration and diabetic eye disease.

Clinical information

Common uses

wet age-related macular degeneration
macular oedema after retinal vein occlusion
diabetic macular oedema
diabetic retinopathy

Common side effects

bleeding on the white of the eye
eye pain
cataract
vitreous floaters or detachment
raised eye pressure

Cautions

not with eye or around-eye infection
not with active inflammation inside the eye
report eye pain or vision changes without delay

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Yesafili (aflibercept-jbvf) label, setid 7d69a7b0-9511-c030-3b85-13b23f9d2980 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
EYLEA™ 40 mg/Ml	Parenteral ( Injection )	40 mg/mL	State Trading Organization Plc	POM